AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients

Angiogenesis represents a rate-limiting step during tumor progression. Targeting angiogenesis is already applied in cancer treatment, yet limits of anti-angiogenic therapies have emerged, notably because tumors adapt and recur after treatment. Therefore, there is a strong need to better understand t...

Descripción completa

Detalles Bibliográficos
Autores principales: Langlois, Benoit, Saupe, Falk, Rupp, Tristan, Arnold, Christiane, van der Heyden, Michaël, Orend, Gertraud, Hussenet, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279391/
https://www.ncbi.nlm.nih.gov/pubmed/25301723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279391/
https://www.ncbi.nlm.nih.gov/pubmed/25301723

Ejemplares similares